For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 1Y
$42.69
Thesis
Tempus AI builds a multimodal clinical and molecular data platform spanning diagnostics, genomic sequencing, and data licensing. Its scaled real-world datasets support both precision diagnostics and AI-enabled drug discovery partnerships.
Catalysts
- Genomics and diagnostics testing volume growth
- Data-licensing and pharma partnership expansion
- Margin progression as the platform scales
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Jul 20OtherSEC
8-K filing (items 7.01, 9.01) disclosing Reg FD information.
- Jul 20M&ASEC
SEC Form 425 filing on business combination communications.
- Jul 20DealSEC
8-K filed with items 1.01 and 9.01 disclosing entry into material definitive agreement.
- Jul 20M&ASEC
SEC Form 425 filing for business combination.
- Jul 20M&ASEC
Tempus AI filed SEC Form 425 regarding a business combination.
- Jul 20M&ASEC
SEC Form 425 filing for business combination communications.
- Jul 20M&ASEC
SEC Form 425 filing for business combination communications.
- May 13OtherSEC
8-K filing with items 1.01, 1.02, 2.03, 3.02, 8.01, 9.01 covering multiple corporate actions.